OTCMKTS:RADLY Raia Drogasil (RADLY) Stock Price, News & Analysis → At first glance, this chart looks like nonsense… (From The TradingPub) (Ad) Free RADLY Stock Alerts $5.48 -0.42 (-7.12%) (As of 04/24/2024 ET) Add Compare Share Share Today's Range$5.01▼$5.9750-Day Range$5.00▼$6.5052-Week Range$4.22▼$8.25Volume876 shsAverage Volume2,033 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartDividendShort InterestStock AnalysisAnalyst ForecastsChartDividendShort Interest Get Raia Drogasil alerts: Email Address Ad Stansberry ResearchThe "Smart Money" Is Ready for May 1st Are You?Former Wall Street VP: "Buy This Stock Now" Five of America's Most Successful Investors Bought Shares in The Same Company. One Former Wall St. Trader Explains Why… About Raia Drogasil Stock (OTCMKTS:RADLY)Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It also markets its goods through telesales and call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.Read More RADLY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RADLY Stock News HeadlinesApril 17, 2024 | americanbankingnews.comRaia Drogasil (OTCMKTS:RADLY) Trading Down 15.3%July 8, 2022 | finance.yahoo.comBrazil’s Battered Stocks Could Rebound, but Not Before the Presidential VoteApril 25, 2024 | Schaeffer’s Research (Ad)Just Released: Insider's Secret to Trading OptionsThis Surprisingly Simple Formula Can Double Your Money Collecting Consistent Profits From The Stock Market Is More Accessible Than You Think A small group of individuals are using a legitimate yet rarely discussed strategy to generate income from the stock market. They're NOT day traders. And they're NOT Wall Street suits either. I'm talking about normal "working stiffs" and retirees generating steady income from a source that 99% of investors completely overlook. This overlooked income source can be yours today.May 5, 2022 | uk.investing.comRaia Drogasil SA ADR (RADLY)See More Headlines Receive RADLY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Raia Drogasil and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 6/10 Dividend4/18/2024Today4/25/2024Dividend Payable6/10/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical Retailers Sub-IndustryN/A Current SymbolOTCMKTS:RADLY CUSIPN/A CIKN/A Webwww.rd.com.br Phone551137695678FaxN/AEmployees57,700Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Marcílio D'Amigo Pousada (Age 59)CEO & Member of Executive Board Mr. Antonio Carlos CoelhoVP of Finance & Administrative and Member of Executive BoardMr. Eugênio De ZagottisVP of Corporate Planning, IR, M&A and Member of Executive BoardMr. Marcello De ZagottisVP of Commercial & Marketing and Member of Executive BoardMr. Fernando Kozel VarelaVP of Digital Transformation & Member of Executive BoardMr. Renato Cepollina RaduanVP of Store, Multichannel & Expansion Operations and Member of Executive BoardMs. Maria Susana De SouzaVP of People, Culture & Sustainability and Member of Executive BoardMr. Bruno Wright PipponziVP of Health Business & Member of Executive BoardCelso Pissi FilhoAccountant & Technical ManagerFlavio FogacaDirector of IR, Corporate Affairs & StrategyMore ExecutivesKey CompetitorsAlibaba Health Information TechnologyOTC:ALBHFAllstar Health BrandsOTCMKTS:ALSTClicks GroupOTCMKTS:CLCGYDocMorrisOTCMKTS:ZRSEFFire & FlowerOTCMKTS:FFLWFView All Competitors RADLY Stock Analysis - Frequently Asked Questions Should I buy or sell Raia Drogasil stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Raia Drogasil in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" RADLY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RADLY, but not buy additional shares or sell existing shares. View RADLY analyst ratings or view top-rated stocks. How have RADLY shares performed in 2024? Raia Drogasil's stock was trading at $7.20 at the beginning of the year. Since then, RADLY stock has decreased by 23.9% and is now trading at $5.48. View the best growth stocks for 2024 here. How often does Raia Drogasil pay dividends? What is the dividend yield for Raia Drogasil? Raia Drogasil announced a dividend on Friday, December 22nd. Shareholders of record on Tuesday, January 2nd will be paid a dividend of $0.0088 per share on Monday, January 8th. The ex-dividend date is Friday, December 29th. This is a boost from the stock's previous dividend of $0.01. Read our dividend analysis for RADLY. When did Raia Drogasil's stock split? Shares of Raia Drogasil split before market open on Monday, May 22nd 2023. The 26-25 split was announced on Monday, May 22nd 2023. The newly issued shares were payable to shareholders after the closing bell on Monday, May 22nd 2023. An investor that had 100 shares of stock prior to the split would have 104 shares after the split. How do I buy shares of Raia Drogasil? Shares of RADLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:RADLY) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceGreat Crypto BullWeiss RatingsFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Raia Drogasil S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.